|
Certain leukemia patients resistant to the drug imatinib mesylate (Gleevec®) can overcome the setback with two more potent targeted therapies, according to new study results. The therapies, known as BMS-354825 and AMN107, appear to be promising for patients with relapsed chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML
Yahoo! Groups Links
|
